Enhanced radiation reaction following combination chemotherapy for small cell carcinoma of the lung, possibly secondary to VP16-213
- 1 May 1982
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (5) , 921-923
- https://doi.org/10.1016/0360-3016(82)90101-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical trial of VP 16–213 (NSC 141540) I.V. Twice weekly in advanced neoplastic disease a study by the cancer and leukemia group BCancer, 1980
- Podophyllotoxin derivative VP 16-213Cancer Chemotherapy and Pharmacology, 1979
- The effectiveness of prophylactic brain irradiation in small cell carcinoma of the lung. A Southwest Oncology Group StudyCancer, 1978
- Small-Cell Carcinoma of the Lung: Combined Chemotherapy and RadiationAnnals of Internal Medicine, 1978
- Adriamycin-irradiation cutaneous complicationsInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976
- Discussion: Combined radiotherapy and chemotherapyCancer, 1976
- Epipodophyllotoxin VP 16213 in Treatment of Acute Leukaemia--Haematosarcoma and Solid TumoursBMJ, 1973